Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Katz

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Investigational New Drugs|June 2, 2011
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinomaAndrew H Ko, Hagop Youssoufian, Jayne Gurtler, et al.
Journal of Autism and Developmental Disorders|June 11, 2013
The Autism Impact Measure (AIM): initial development of a new tool for treatment outcome measurementStephen M Kanne, Micah O Mazurek, Darryn Sikora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2010
A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignanciesBart Kuenen, Petronella O Witteveen, Rita Ruijter, et al.
The Lancet. Oncology|November 16, 2013
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trialEdward S Kim, Marcus Neubauer, Allen Cohn, et al.
Journal of Autism and Developmental Disorders|June 12, 2013
Parent-based sleep education for children with autism spectrum disordersBeth A Malow, Karen W Adkins, Ann Reynolds, et al.
Pediatrics|August 16, 2018
Family-Driven Goals to Improve Care for Children With Autism Spectrum DisorderKatherine R Bellesheim, Lynn Cole, Daniel L Coury, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|June 1, 2016
The Pediatric Sleep Clinical Global Impressions Scale-A New Tool to Measure Pediatric Insomnia in Autism Spectrum DisordersBeth A Malow, Heidi V Connolly, Shelly K Weiss, et al.
Pediatric Neurology|January 10, 2020
Randomized, Placebo-Controlled Trial of Ferrous Sulfate to Treat Insomnia in Children With Autism Spectrum DisordersAnn M Reynolds, Heidi V Connolly, Terry Katz, et al.
Journal of Veterinary Internal Medicine|June 5, 2026
Efficacy and safety evaluation of gilvetmab in dogs with melanoma and mast cell tumorEsther Chon, Mohamad Morsey, Terry Katz, et al.
Molecular Genetics & Genomic Medicine|February 12, 2022
A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndromeJessica Duis, Mark Nespeca, Jane Summers, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Investigational New Drugs|June 2, 2011
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinomaAndrew H Ko, Hagop Youssoufian, Jayne Gurtler, et al.
Journal of Autism and Developmental Disorders|June 11, 2013
The Autism Impact Measure (AIM): initial development of a new tool for treatment outcome measurementStephen M Kanne, Micah O Mazurek, Darryn Sikora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2010
A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignanciesBart Kuenen, Petronella O Witteveen, Rita Ruijter, et al.
The Lancet. Oncology|November 16, 2013
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trialEdward S Kim, Marcus Neubauer, Allen Cohn, et al.
Journal of Autism and Developmental Disorders|June 12, 2013
Parent-based sleep education for children with autism spectrum disordersBeth A Malow, Karen W Adkins, Ann Reynolds, et al.
Pediatrics|August 16, 2018
Family-Driven Goals to Improve Care for Children With Autism Spectrum DisorderKatherine R Bellesheim, Lynn Cole, Daniel L Coury, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|June 1, 2016
The Pediatric Sleep Clinical Global Impressions Scale-A New Tool to Measure Pediatric Insomnia in Autism Spectrum DisordersBeth A Malow, Heidi V Connolly, Shelly K Weiss, et al.
Pediatric Neurology|January 10, 2020
Randomized, Placebo-Controlled Trial of Ferrous Sulfate to Treat Insomnia in Children With Autism Spectrum DisordersAnn M Reynolds, Heidi V Connolly, Terry Katz, et al.
Journal of Veterinary Internal Medicine|June 5, 2026
Efficacy and safety evaluation of gilvetmab in dogs with melanoma and mast cell tumorEsther Chon, Mohamad Morsey, Terry Katz, et al.
Molecular Genetics & Genomic Medicine|February 12, 2022
A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndromeJessica Duis, Mark Nespeca, Jane Summers, et al.
Pageof 3